AZD0530; N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine
379231-04-6
542.03
C27H32ClN5O5
DMF, DMSO, DMSO:PBS (pH 7.2)[1:1]
-20°C
Saracatinib is a dually active inhibitor of c-Src and Bcr-ABL, on bone resorption. AZD0530 inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of focal adhesion kinase (FAK) and paxillin in a dose-dependent manner in a Calu-6 Xenograft model.
0.1 lbs
Research or further manufacturing use only, not for food or drug use.
